- Home
- IPSC vs GUTS Comparison
IPSC vs GUTS Comparison
Compare IPSC & GUTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- GUTS
- Stock Information
- Founded
- IPSC 2019
- GUTS 2010
- Country
- IPSC United States
- GUTS United States
- Employees
- IPSC N/A
- GUTS N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- GUTS
- Sector
- IPSC Health Care
- GUTS
- Exchange
- IPSC Nasdaq
- GUTS NYSE
- Market Cap
- IPSC 58.1M
- GUTS 58.9M
- IPO Year
- IPSC 2021
- GUTS 2024
- Fundamental
- Price
- IPSC $0.48
- GUTS $1.19
- Analyst Decision
- IPSC Strong Buy
- GUTS Buy
- Analyst Count
- IPSC 5
- GUTS 1
- Target Price
- IPSC $4.67
- GUTS $10.00
- AVG Volume (30 Days)
- IPSC 480.0K
- GUTS 201.2K
- Earning Date
- IPSC 03-19-2025
- GUTS 03-03-2025
- Dividend Yield
- IPSC N/A
- GUTS N/A
- EPS Growth
- IPSC N/A
- GUTS N/A
- EPS
- IPSC N/A
- GUTS N/A
- Revenue
- IPSC $6,589,000.00
- GUTS $93,000.00
- Revenue This Year
- IPSC N/A
- GUTS N/A
- Revenue Next Year
- IPSC N/A
- GUTS N/A
- P/E Ratio
- IPSC N/A
- GUTS N/A
- Revenue Growth
- IPSC 194.81
- GUTS N/A
- 52 Week Low
- IPSC $0.47
- GUTS $1.16
- 52 Week High
- IPSC $4.43
- GUTS $7.89
- Technical
- Relative Strength Index (RSI)
- IPSC 26.49
- GUTS 36.85
- Support Level
- IPSC $0.54
- GUTS $1.19
- Resistance Level
- IPSC $0.59
- GUTS $1.32
- Average True Range (ATR)
- IPSC 0.05
- GUTS 0.08
- MACD
- IPSC -0.00
- GUTS 0.01
- Stochastic Oscillator
- IPSC 3.08
- GUTS 13.64
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.
About GUTS FRACTYL HEALTH INC
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.